Adalimumab induced-inflammatory myopathy in rheumatoid arthritis].

Fernando Henrique Carlos de Souza, Thiago Bitar Morais Barros, Mauricio Levy-Neto, Samuel Katsuyuki Shinjo

Serviço de Reumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP), São Paulo.

Acta reumatológica portuguesa 2012 Apr-Jun

filter terms:

The application of immunobiologics for the rheumatoid arthritis treatment may present as a rare complication the development of inflammatory myopathy. Until this moment, there have been described in literature only seven cases of inhibitors of tumor necrosis factor induced-myositis. In this paper, we report the case of the patient with 39 years-old with eight years of arthritis rheumatoid and that due to refractory to various immunosuppressive drugs, the adalimumab was introduced, and evolved to dermatomyositis status.

Citation

Fernando Henrique Carlos de Souza, Thiago Bitar Morais Barros, Mauricio Levy-Neto, Samuel Katsuyuki Shinjo. Adalimumab induced-inflammatory myopathy in rheumatoid arthritis]. Acta reumatológica portuguesa. 2012 Apr-Jun;37(2):180-3

PMID: 23149641

View Full Text